CORC

浏览/检索结果: 共107条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Chiral metal-organic frameworks and their composites as stationary phases for liquid chromatography chiral separation: A minireview 期刊论文
Journal of Chromatography A, 2023, 期号: 1700, 页码: 464032
作者:  Chunqiang Liu;  Kaijun Quan;  Jia Chen;  Xiaofeng Shi;  Hongdeng Qiu
收藏  |  浏览/下载:17/0  |  提交时间:2023/05/23
ET White Paper: To Find the First Earth 2.0 预印本
2022
作者:  Ge, Jian;  Zhang, Hui;  Zang, Weicheng;  Deng, Hongping;  Mao, Shude
收藏  |  浏览/下载:48/0  |  提交时间:2022/07/29
Synthesis of chiral functionalized UiO-66-NH2@SiO2 and use of its domain-limiting effect for separating small enantiomers 期刊论文
CHEMICAL COMMUNICATIONS, 2022, 期号: 58, 页码: 13111
作者:  
收藏  |  浏览/下载:3/0  |  提交时间:2022/11/30
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载:61/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:50/0  |  提交时间:2019/12/05
Magnetic Resonance Imaging (MRI) and Three-Dimensional Transvaginal Ultrasonography Scanning for Preoperative Assessment of High Risk in Women with Endometrial Cancer 期刊论文
MEDICAL SCIENCE MONITOR, 2019, 卷号: 25, 页码: 2024-2031
作者:  Yang, Ting;  Tian, Sijuan;  Li, Yang;  Tian, Xueye;  Wang, Wei
收藏  |  浏览/下载:23/0  |  提交时间:2019/11/19
Quantity Commitment Strategy and Effectiveness Analysis With Disappointment Aversion Strategic Consumers 期刊论文
IEEE Access, 2019, 卷号: 7, 页码: 67094-67106
作者:  Quan, Ji*;  Wang, Xiaofeng;  Li, Chenghao*;  Xia, De
收藏  |  浏览/下载:23/0  |  提交时间:2019/12/04
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:39/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:41/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace